Science

AddToAny

Google+ Facebook Twitter Twitter

Review, refresh and reimagine

A look back at how the Blood Stocks Management Scheme has evolved over the last two decades, some recent achievements, and what is planned for the next 20 years.

The Blood Stocks Management Scheme (BSMS) was established in April 2001, as a partnership between hospital blood transfusion laboratories and the then National Blood Service (NBS) upon request of the Department of Health, not only to maximise the use of donated blood, but to develop a deeper understanding of blood inventory management across the whole supply chain, which up to that point was largely held locally and unknown at the national level.

The scheme collects hospital red cell stock data, component issues and wastage data, together with blood centre stock levels and wastage, to support demand forecasting, identify trends and focus on wastage reduction. Analysis and reporting of hospital data encourages performance monitoring between peers, highlights good practice and has been pivotal for setting new key performance indicators. 

Please click here to read the full article

Image credit | Getty

Related Articles

Transfusion: training hub

Jill Caulfield, Transfusion 2024 Education Development Lead at NHS Blood and Transplant, introduces a “one-stop shop” of training resources.

VR-headset - CREDIT -getty

Improving transfusion with training

Ruth Evans and Laura Eastwood from NHS Blood and Transplant discuss virtual reality training for blood transfusion testing.

red blood cells CREDIT-iStock-1227353965

Casestudy acquired protein s deficiency

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study in which a two-year-old presented with an unprovoked extensive deep vein thrombosis.

paper cuts - CREDIT - Richard-Gleed

DNA: Cutting the future of genome editing

The latest CRISPR-Cas technology has been used to eliminate all traces of HIV from infected cells in the lab. Here we look at how gene editing could revolutionise clinical treatments and ask what the limitations are for its future use.

Top